Mostrar el registro sencillo del ítem
Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: Role of brain innate immune system
dc.contributor.author | Leszek J. | |
dc.contributor.author | Barreto G.E. | |
dc.contributor.author | Gąsiorowski K. | |
dc.contributor.author | Koutsouraki E. | |
dc.contributor.author | Ávila-Rodrigues M. | |
dc.contributor.author | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:21:46Z | |
dc.date.available | 2020-09-02T22:21:46Z | |
dc.date.issued | 2016 | |
dc.identifier | 10.2174/1871527315666160202125914 | |
dc.identifier.citation | 15, 3, 329-336 | |
dc.identifier.issn | 18715273 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5093 | |
dc.description | Chronic inflammation is characterized by longstanding microglial activation followed by sustained release of inflammatory mediators, which aid in enhanced nitrosative and oxidative stress. The sustained release of inflammatory mediators propels the inflammatory cycle by increased microglial activation, promoting their proliferation and thus stimulating enhanced release of inflammatory factors. Elevated levels of several cytokines and chronic neuroinflammation have been associated with many neurodegenerative disorders of central nervous system like age-related macular degeneration, Alzheimer disease, multiple sclerosis, Parkinson’s disease, Huntington’ disease, and tauopathies. This review highlights the basic mechanisms of neuroinflammation, the characteristics of neurodegenerative diseases, and the main immunologic responses in CNS neurodegenerative disorders. A comprehensive outline for the crucial role of microglia in neuroinflammation and neurodegeneration and the role of Toll-like receptor signalling in coexistence of inflammatory mechanisms and oxidative stress as major factors responsible for progression of neurodegeneration have also been presented. © 2016 Bentham Science Publishers. | |
dc.language.iso | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Microglia | |
dc.subject | Neurodegenerative disorders | |
dc.subject | Neuroinflammation | |
dc.subject | Oxidative stress | |
dc.subject | Toll-like receptors | |
dc.subject | CD11b antigen | |
dc.subject | CD14 antigen | |
dc.subject | CD200 antigen | |
dc.subject | CD200 receptor | |
dc.subject | CD36 antigen | |
dc.subject | CD47 antigen | |
dc.subject | chaperonin 60 | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | intercellular adhesion molecule 1 | |
dc.subject | interferon regulatory factor 3 | |
dc.subject | interferon regulatory factor 5 | |
dc.subject | interferon regulatory factor 7 | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 6 | |
dc.subject | lymphocyte function associated antigen 1 | |
dc.subject | monocyte chemotactic protein 1 | |
dc.subject | nitric oxide | |
dc.subject | reactive oxygen metabolite | |
dc.subject | scavenger receptor A | |
dc.subject | toll like receptor | |
dc.subject | toll like receptor 1 | |
dc.subject | toll like receptor 2 | |
dc.subject | toll like receptor 4 | |
dc.subject | toll like receptor 5 | |
dc.subject | toll like receptor 7 | |
dc.subject | transcription factor AP 1 | |
dc.subject | tumor necrosis factor | |
dc.subject | unindexed drug | |
dc.subject | vascular cell adhesion molecule 1 | |
dc.subject | very late activation antigen 6 | |
dc.subject | cytokine | |
dc.subject | Alzheimer disease | |
dc.subject | Article | |
dc.subject | blood brain barrier | |
dc.subject | cell survival | |
dc.subject | central nervous system | |
dc.subject | disease course | |
dc.subject | DNA polymorphism | |
dc.subject | gene mutation | |
dc.subject | human | |
dc.subject | innate immunity | |
dc.subject | microglia | |
dc.subject | nerve degeneration | |
dc.subject | nervous system inflammation | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | protein expression | |
dc.subject | signal transduction | |
dc.subject | animal | |
dc.subject | brain | |
dc.subject | degenerative disease | |
dc.subject | disease course | |
dc.subject | immunology | |
dc.subject | inflammation | |
dc.subject | innate immunity | |
dc.subject | metabolism | |
dc.subject | oxidative stress | |
dc.subject | pathology | |
dc.subject | pathophysiology | |
dc.subject | physiology | |
dc.subject | Animals | |
dc.subject | Brain | |
dc.subject | Cytokines | |
dc.subject | Disease Progression | |
dc.subject | Humans | |
dc.subject | Immunity, Innate | |
dc.subject | Inflammation | |
dc.subject | Microglia | |
dc.subject | Neurodegenerative Diseases | |
dc.subject | Oxidative Stress | |
dc.title | Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: Role of brain innate immune system | |
dc.type | Article |